产品中心

产品货号

产品名称

规格

销售价

会员价

货期

产地

订购

CB92

Recombinant Human CCL22/MDC

10ug

640

576

现货

国产

CB92

Recombinant Human CCL22/MDC

50ug

1760

1584

现货

国产

CB92

Recombinant Human CCL22/MDC

500ug

12320

11088

现货

国产

CB92

Recombinant Human CCL22/MDC

1mg

17600

15840

现货

国产

  • 产品简介
  • 使用说明
  • 相关产品
  • 参考文献
  • 购买咨询
  • Catalog# CB92
    Source Human Cells
    Description Recombinant Human CCL22/MDC is produced by our mammalian expression system in human cells. The target protein is expressed with sequence (Gly25-Gln93) of Human CCL22 fused with a polyhistidine tag at the C-terminus.
    Names C-C motif chemokine 22,CC chemokine STCP-1,Macrophage-derived
    Accession # O00626
    Shipping The product is shipped at ambient temperature.
    Reconstitution Always centrifuge tubes before opening. Do not mix by vortex or pipetting.
    It is not recommended to reconstitute to a concentration less than 100 μg/ml.
    Dissolve the lyophilized protein in 1X PBS.
    Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
    Storage Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks.
    Reconstituted protein solution can be stored at 4-7°C for 2-7 days.
    Aliquots of reconstituted samples are stable at < -20°C for 3 months.
    Purity Greater than 95% as determined by SEC-HPLC and reducing SDS-PAGE.
    Endotoxin Less than 0.1 ng/µg (1 IEU/µg).
    Amino Acid Sequence
    GPYGANMEDS VCCRDYVRYR LPLRVVKHFY WTSDSCPRPG VVLLTFRDKE ICADPRVPWV KMILNKLSQV DHHHHHH
    Background Macrophage-derived chemokine (MDC), also named stimulated T cell chemotactic protein (STCP-1) and ABCD-1, and now designated as CCL22, is a CC chemokine initially isolated from clones of monocyte-derived macrophages. At the amino acid sequence level, MDC shows less than 35% identity to other CC chemokine family members. Human MDC is expressed in dendritic cells, macrophages and activated monocytes. In addition, MDC expression is detected in thymus, lymph node and appendix tissues.